Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer's disease: an exploratory study of 18F-FDG-PET

被引:6
|
作者
Zhang, Qi [1 ]
Fan, Chunqiu [2 ]
Wang, Luyao [3 ]
Li, Taoran [4 ]
Wang, Min [3 ]
Han, Ying [2 ,5 ,6 ,7 ]
Jiang, Jiehui [3 ,8 ]
机构
[1] Shanghai Univ, Sch Commun & Informat Engn, Shanghai 200444, Peoples R China
[2] Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing 100053, Peoples R China
[3] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China
[4] Nanjing Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China
[5] Hainan Univ, Sch Biomed Engn, Haikou 570228, Peoples R China
[6] Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing 100053, Peoples R China
[7] Natl Clin Res Ctr Geriatr Dis, Beijing 100053, Peoples R China
[8] Nucl Med & Mol Imaging Key Lab Sichuan Prov, Luzhou 646000, Sichuan, Peoples R China
基金
美国国家卫生研究院;
关键词
Cognitively unimpaired; FDG PET; Kaplan-Meier analysis; Neurodegeneration; Posterior cingulate cortex; ASSOCIATIONS; IMPAIRMENT; BIOMARKERS; DIAGNOSIS; FRAMEWORK; IMPROVES; DECLINE; TAU; FDG; CSF;
D O I
10.1007/s11357-023-00897-0
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Amyloid-ss (A ss) and tau are important biomarkers to predict the progression of cognitively unimpaired (CU) to dementia due to Alzheimer's disease (AD), according to the diagnosis framework from the US National Institute on Aging and the Alzheimer's Association (NIA-AA). However, it is clinically difficult to predict those subjects who were already with A ss positive (A +) or tau positive (T +). As a typical characteristic of neurodegeneration in the diagnosis framework, the hypometabolism of the posterior cingulate cortex (PCC) has significant clinical value in the early prediction and prevention of AD. In this paper, we proposed the glucose metabolism in the PCC as a biomarker supplement to A ss and tau biomarkers. First, we calculated the standard uptake value ratio (SUVR) of PCC based on fluorodeoxyglucose positron emission computed tomography (FDG PET) imaging. Secondly, we performed Kaplan-Meier (KM) survival analyses to explore the predictive performance of PCC SUVR, and the hazard ratio (HR) was calculated. Finally, we performed Pearson correlation analyses to explore the physiological significance of PCC SUVR. As a result, the PCC SUVR showed a consistent downward trend along the AD continuum. KM analyses showed better predictive performance when we combined PCC SUVR with cerebro-spinal fluid (CSF) A ss(42) (from HR= 2.56 to 3.00 within 5 years; from HR = 2.76 to 4.20 within 10 years) and ptau-181 (from 2.83 to 3.91 within 5 years; from HR = 2.32 to 4.17 within 10 years). There was a slight correlation between A ss(42)/A ss(40) and PCC SUVR (r = 0.14, p = 0.02). In addition, several cognition scales were also correlated to PCC SUVR (from r = -0.407 to 0.383, p < 0.05). Our results showed that glucose metabolism in PCC may be a potential biomarker supplement to the A ss and tau biomarkers to predict the progression of CU to AD.
引用
收藏
页码:1407 / 1420
页数:14
相关论文
共 48 条
  • [1] Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer’s disease: an exploratory study of 18F-FDG-PET
    Qi Zhang
    Chunqiu Fan
    Luyao Wang
    Taoran Li
    Min Wang
    Ying Han
    Jiehui Jiang
    GeroScience, 2024, 46 : 1407 - 1420
  • [2] Cerebral Glucose Metabolism Assessment in Rat Models of Alzheimer's Disease: An 18F-FDG-PET Study
    Lu, Yangjia
    Ren, Jie
    Cui, Shaoyang
    Chen, Junqi
    Huang, Yong
    Tang, Chunzhi
    Shan, Baoci
    Nie, Bingbing
    Lai Xinsheng
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2016, 31 (04): : 333 - 340
  • [3] Brain 18F-FDG-PET and an optimized cingulate island ratio to differentiate Lewy body dementia and Alzheimer's disease
    Woyk, Katharina
    Sahlmann, Carsten Oliver
    Hansen, Niels
    Timaeus, Charles
    Mueller, Sebastian Johannes
    Khadhraoui, Eya
    Wiltfang, Jens
    Lange, Claudia
    Bouter, Caroline
    JOURNAL OF NEUROIMAGING, 2023, 33 (02) : 256 - 268
  • [4] Gender Differences in Aging and Alzheimer's Dementia: an 18F-FDG-PET Study
    Malpetti, M.
    Ballarini, T.
    Presotto, L.
    Garibotto, V.
    Perani, D.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 : S43 - S43
  • [5] A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease
    Gjerum, Le
    Frederiksen, Kristian Steen
    Henriksen, Otto Molby
    Law, Ian
    Anderberg, Lasse
    Andersen, Birgitte Bo
    Bjerregaard, Eva
    Heji, Anne-Mette
    Hogh, Peter
    Hasselbalch, Steen Gregers
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 410
  • [6] Effects of acupuncture at HT7 on glucose metabolism in a rat model of Alzheimer's disease: an 18F-FDG-PET study
    Lai, Xinsheng
    Ren, Jie
    Lu, Yangjia
    Cui, Shaoyang
    Chen, Junqi
    Huang, Yong
    Tang, Chunzhi
    Shan, Baoci
    Nie, Bingbing
    ACUPUNCTURE IN MEDICINE, 2016, 34 (03) : 215 - 222
  • [7] Gender differences in healthy aging and Alzheimer's Dementia: A 18F-FDG-PET study of brain and cognitive reserve
    Malpetti, Maura
    Ballarini, Tommaso
    Presotto, Luca
    Garibotto, Valentina
    Tettamanti, Marco
    Perani, Daniela
    HUMAN BRAIN MAPPING, 2017, 38 (08) : 4212 - 4227
  • [8] Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: A prospective 18F-FDG-PET study
    Grimmer, T
    Drzezga, A
    Foerstl, H
    Kurz, A
    NEUROLOGY, 2004, 62 (07) : A297 - A297
  • [9] Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia:: A prospective 18F-FDG-PET study
    Grimmer, T
    Diehl, J
    Drzezga, A
    Förstl, H
    Kurz, A
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 18 (01) : 32 - 36
  • [10] [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease
    Okamura, N
    Arai, H
    Higuchi, M
    Tashiro, M
    Matsui, T
    Hu, XS
    Takeda, A
    Itoh, M
    Sasaki, H
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2001, 25 (02): : 447 - 456